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Résumé en
anglais
Array-CGH has revealed a large number of copy number variations (CNVs) in
patients with multiple congenital anomalies and/or mental retardation (MCA/MR).
According to criteria recently listed, pathogenicity was clearly suspected for some
CNVs but benign CNVs, considered as polymorphisms, have complicated the
interpretation of the results. In this study, genomic DNAs from 132 French patients
with unexplained mental retardation were analysed by genome wide high-resolution
Agilent 44K oligonucleotide arrays. The results were in accordance with those
observed in previous studies: the detection rate of pathogenic CNVs was 14.4%. A
non-random involvement of several chromosomal regions was observed. Some of the
microimbalances recurrently involved regions (1q21.1, 2q23.1, 2q32q33, 7p13,
17p13.3, 17p11.2, 17q21.31) corresponding to known or novel syndromes. For all
the pathogenic CNVs, further cases are needed to allow more accurate genotype-
phenotype correlations underscoring the importance of databases to group patients
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